Results 1 to 10 of about 10,560 (136)

Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006–2015 [PDF]

Human Vaccines & Immunotherapeutics, 2018
Background: Herpes zoster (HZ), or shingles, is caused by reactivation of varicella-zoster virus in latently infected individuals. Live-attenuated HZ vaccine (zoster vaccine live, ZVL) is approved in the United States for persons aged ≥50 years and ...
Elaine R. Miller, Paige Lewis, Tom T. Shimabukuro, John Su, Pedro Moro, Emily Jane Woo, Christopher Jankosky, Maria Cano   +7 more
doaj   +3 more sources

Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine

Human Vaccines & Immunotherapeutics, 2020
Herpes zoster (shingles) is a painful condition resulting from reactivation of latent varicella zoster virus (VZV). The Australian National Shingles Vaccination Program (commenced November 2016) provides free herpes zoster vaccination for eligible adults
John Litt, Robert Booy, Debra Bourke, Dominic E. Dwyer, Alan Leeb, Philip McCloud, Alicia N. Stein, Michael Woodward, Anthony L. Cunningham   +8 more
doaj   +2 more sources

Risk factors for modified vaccine effectiveness of the live attenuated zoster vaccine among the elderly in England

Vaccine: X, 2019
Background: The United Kingdom introduced routine vaccination with the live-attenuated zoster vaccine for 70 year-olds in 2013, with the vaccine also offered to 79 year-olds as part of a catch-up campaign.
Kaatje Bollaerts, Maria Alexandridou, Thomas Verstraeten   +2 more
doaj   +3 more sources

Cost-Effectiveness Analysis of Herpes Zoster Vaccination in a Chinese Population: Recombinant Subunit Vaccine versus Live Attenuated Vaccine

Vaccines
Background: Currently, the recombinant subunit vaccine and live attenuated vaccine in the prevention of herpes zoster are approved for marketing in China.
Jiaqi Wang, Pengfei Jin, Hui Jin, Qiang Wang, Fengcai Zhu, Jingxin Li   +5 more
doaj   +3 more sources

Herpes zoster vaccine live: A 10 year review of post-marketing safety experience [PDF]

Vaccine, 2017
Zoran Popmihajlov, Patricia Saddier, Neal A Halsey   +2 more
exaly   +2 more sources

Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live [PDF]

Human Vaccines and Immunotherapeutics, 2019
Desmond Curran, Brandon J Patterson, Desirée Van Oorschot   +2 more
exaly   +2 more sources

Primary care physicians’ experience with zoster vaccine live (ZVL) and awareness and attitudes regarding the new recombinant zoster vaccine (RZV) [PDF]

Vaccine, 2018
Laura P Hurley, Kathleen L Dooling, Michaela Brtnikova   +2 more
exaly   +2 more sources

Prevention of Herpes Zoster: A Focus on the Effectiveness and Safety of Herpes Zoster Vaccines

Viruses, 2022
Infection with varicella zoster virus typically occurs in children and it can cause primary varicella infection or “chickenpox”, or it can reactivate later in life and cause herpes zoster or “shingles”.
Yasmin Marra, Fawziah Lalji
doaj   +1 more source

Herpes zoster following COVID-19 vaccination in an immunocompetent and vaccinated for herpes zoster adult: A two-vaccine related event?

Metabolism Open, 2022
Reactivation of varicella-zoster virus (VZV) has been reported after the administration of different vaccine platforms against SARS-CoV-2, also among individuals without known immunosuppressive states.
Natalia G. Vallianou, Dimitrios Tsilingiris, Irene Karampela, Junli Liu, Maria Dalamaga   +4 more
doaj   +1 more source

Herpes zoster vaccination. An update

Przegląd Dermatologiczny, 2022
Herpes zoster/shingles is a cutaneous condition caused by the reactivation of varicella zoster virus. The condition mostly occurs when the cell mediated immunity towards varicella zoster virus, which was developed during the varicella zoster virus ...
Khairuddin Djawad, Safruddin Amin, Anni Adriani, Widyawati Djamaluddin, Dirmawati Kadir, Sri Muchtar   +5 more
doaj   +1 more source